Medical device and MedTech insights, news, tips and more

ZipThaw, the World’s First Portable, Precise Plasma Thawing Medical Device, Receives FDA Clearance for Clinical Use

January 6, 2020

FreMon Scientific ZipThaw

FreMon Scientific is pleased to announce the FDA has now cleared ZipThaw™ for frozen plasma thawing as a Class II medical device. ZipThaw, used with the ZipSleeve™ anti-contaminant disposable barrier, is the world’s first dry and portable precision plasma thawing system. Clinicians can now deliver vital plasma to patients at the right time and temperature.

FreMon Scientific ZipThaw

ZipThaw and ZipSleeve have earned CE Mark, ISO certification, UL Listing and now FDA clearance for thawing fresh frozen plasma (FFP) and plasma frozen within 24 hours after phlebotomy (FP24).

“We are delighted with the FDA’s clearance of ZipThaw as an effective and safe plasma thawing device for clinical use,” said FreMon Scientific CEO Dr. Farideh Bischoff.

“ZipThaw delivers plasma to patients requiring transfusions, and with ZipSleeve’s patented sensors, the system gives accurate, degree-by-degree measurement of the specimen’s actual temperature during the thawing process, not its surroundings. Today marks a new era in plasma thawing for patients, clinicians, and researchers seeking a more effective approach that is efficient, reproducible and safe.”

In most of the world, blood banks thaw plasma using hot water baths. The water baths are heavy, they require significant bench space, they are difficult to keep clean and often lead to waste since clinicians have to pre-order thawed plasma from a central location. They also only measure ambient water temperature, not the specimen’s actual temperature.

FreMon Scientific has designed the next generation thawing device that is safe, dry, easy to use, light enough to carry, and that uses a disposable, medical-grade sleeve to reduce contamination and increase accuracy. ZipThaw is proven to preserve coagulation factors needed in life saving transfusion procedures.

ZipThaw requires nearly no maintenance, thawing is precisely measured and the end-to-end thawing process is easier to manage with fewer technical staff.

“We are excited to start the new year with the opportunity to provide clinicians with an effective device that can improve their patients’ lives,” says CEO Dr. Bischoff.

See Full Press Release: ZipThaw Receives FDA Clearance for Clinical Use


Written by: FreMon Scientific, Inc.


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.